A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...
Shares of GSK PLC GSK inched up 0.33% to £13.59 Tuesday, on what proved to be an all-around positive trading session for the ...
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...
Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...
The European Commission approves GSK's Jemperli plus chemotherapy to treat all adult patients with primary, advanced or recurrent endometrial cancer.
Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...
With so many UK residents already earning a second income from their Stocks and Shares ISA, here's a strategy for new ...
This FTSE 100 commodity giant looks to me to be in a prime position to benefit from the energy transition, which could drive its share price much higher.
BioVersys is working on producing new antibiotics to tackle antimicrobial-resistant diseases. The IPO will help it take its ...